Healthcare providers' perspectives on implementing a primary care-based initiative to increase equitable bowel cancer screening participation in Australia.

Authors

Joyce Jiang, Edwin Zou, Lanxi Huang, Jennifer McIntosh, Mark Jenkins, Carlene Wilson

Published in

Health promotion international. Volume 41. Issue 5. Sep 01, 2026.

Abstract

Bowel cancer is the fifth most common cancer in Australia and the second leading cause of cancer-related death. Although the National Bowel Cancer Screening Program mails test kits to eligible Australians, uptake remains suboptimal, particularly among underserved populations. The Alternative Access Model (AAM) is a primary care-based strategy through which healthcare providers (HCPs) distribute kits directly to eligible patients, enabling practitioner endorsement and patient navigation. This study explored HCPs' perceptions of the acceptability, feasibility, barriers, and enablers of implementing the AAM in general practices serving ethnically and socioeconomically diverse populations. Semi-structured interviews were conducted with primary HCPs in Melbourne, Australia. Nine general practice clinics participated in a two-phase study. Thirty-seven interviews were conducted with general practitioners (n = 13), practice nurses (n = 15), and practice managers (n = 9). Data were analysed using NVivo 15. Most participants (89%) were unfamiliar with the AAM. Once explained, the model was perceived as acceptable because it aligns with primary care's preventive role; however, implementation would be feasible only if barriers such as lack of financial incentives, system integration, and maintenance are addressed and provided. Improving equitable access requires more than making screening kits available. Tailored, culturally responsive, multi-faceted resources that could address perceived low bowel health literacy and cultural beliefs about screening, along with practitioners' endorsement and encouragement, and enhanced patient navigation within primary care are perceived having potential benefits in supporting more equitable bowel cancer screening participation among underserved populations.

PMID:
42867088
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.